Acreage Holdings, Inc. ACRG (ACRG.B.U) ACRDF reported its financial results Tuesday for the third quarter ended Sept. 30, 2023, revealing consolidated revenue of $56.5 million, an 8% year-over-year and 2.8% quarter-over-quarter decrease.
The New York-based cannabis company also reported its eleventh consecutive quarter of positive adjusted EBITDA of $6.6 million, compared to an $8.8 million adjusted EBITDA gain in the same quarter of 2022.
Q3 2023 Financial Highlights
- Gross profit was $21.27 million, compared to gross profit of $21.26 million in the corresponding quarter of last year.
- Net operating loss was $2.5 million, down from $16.4 million in the third quarter of 2022.
- Net loss amounted to $7.8 million, down from $25 million in the prior year’s period.
- As of Sept. 30, total assets amounted to $355.78 million, down from $360.57 million on Dec. 31.
- Ended the quarter with $15.1 million in cash and cash equivalents and $9.7 million of restricted cash, with such funds restricted to be used for eligible capital expenditures.
Key Q3 And Recent Operational Highlights
- Recorded a 27% increase in Connecticut sales for the nine months ended Sept. 30, compared to the nine months ended Sept. 30, 2022, with The Botanist Danbury achieving the highest individual store growth with a 64% increase year-over-year.
- Achieved strong results in New Jersey, including the highest statewide year-over-year sales growth with an increase of 34% for year-to-date compared to the same period of last year. Further, New Jersey wholesale revenue reached $1 million for the month of Aug. 2023.
- Commenced construction on a new dispensary in Vernon, Connecticut, which will be the company’s third hybrid location in the state. The Botanist Vernon is anticipated to open in April 2024.
“I’m proud of the progress the team made in Q3 building a company focused on strong brands and implementing a cost structure that will allow for future growth,” Dennis Curran, the company’s CEO said. “In particular, New Jersey and Connecticut remain strong areas of performance for our business, once again delivering record results and robust year-over-year growth.”
ACRDF Price Action
Acreage’s shares traded 3.1554% lower at $0.275 per share after the market close on Tuesday afternoon.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF
Related News
- Acreage Holdings: Q2 Revenue $58.1M, Boasts Record Revenue In NJ And CT, Positive Adjusted EBITDA
- Acreage Q1 Revenue Declines 1.6% YoY, What About Adjusted EBITDA?
Photo: Courtesy of Giorgio Trovato on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.